Skip to main content
Top
Published in: Archives of Virology 3/2024

01-03-2024 | Brief Report

Isolation and genome-wide analysis of the novel Acinetobacter baumannii bacteriophage vB_AbaM_AB3P2

Authors: Yujing Tan, Jianhui Su, Dandan Luo, Bingshao Liang, Shenshen Liu, Haiyan Zeng

Published in: Archives of Virology | Issue 3/2024

Login to get access

Abstract

A lytic Acinetobacter baumannii phage, isolate vB_AbaM_AB3P2, was isolated from a sewage treatment plant in China. A. baumannii phage vB_AbaM_AB3P2 has a dsDNA genome that is 44,824 bp in length with a G + C content of 37.75%. Ninety-six open reading frames were identified, and no genes for antibiotic resistance or virulence factors were found. Genomic and phylogenetic analysis of this phage revealed that it represents a new species in the genus Obolenskvirus. Phage vB_AbaM_AB3P2 has a short latent period (10 min) and high stability at 30–70°C and pH 2–10 and is potentially useful for controlling multi-drug-resistant A. baumannii.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dijkshoorn L, Nemec A, Seifert H (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5:939–951CrossRefPubMed Dijkshoorn L, Nemec A, Seifert H (2007) An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 5:939–951CrossRefPubMed
2.
go back to reference Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN (2021) Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep 48:6987–6998CrossRefPubMedPubMedCentral Ibrahim S, Al-Saryi N, Al-Kadmy IMS, Aziz SN (2021) Multidrug-resistant Acinetobacter baumannii as an emerging concern in hospitals. Mol Biol Rep 48:6987–6998CrossRefPubMedPubMedCentral
3.
go back to reference Chang RYK, Nang SC, Chan HK, Li J (2022) Novel antimicrobial agents for combating antibiotic-resistant bacteria. Adv Drug Deliv Rev 187:114378CrossRefPubMed Chang RYK, Nang SC, Chan HK, Li J (2022) Novel antimicrobial agents for combating antibiotic-resistant bacteria. Adv Drug Deliv Rev 187:114378CrossRefPubMed
4.
go back to reference Tan Y, Su J, Fu M, Zhang H, Zeng H (2023) Recent Advances in Phage-Based Therapeutics for Multi-Drug Resistant Acinetobacter baumannii. Bioeng (Basel Switzerland) 10(1):35 Tan Y, Su J, Fu M, Zhang H, Zeng H (2023) Recent Advances in Phage-Based Therapeutics for Multi-Drug Resistant Acinetobacter baumannii. Bioeng (Basel Switzerland) 10(1):35
5.
go back to reference Peng W, Zeng F, Wu Z, Jin Z, Li W, Zhu M, Wang Q, Tong Y, Chen L, Bai Q (2021) Isolation and genomic analysis of temperate phage 5W targeting multidrug-resistant Acinetobacter baumannii. Arch Microbiol 204:58CrossRefPubMed Peng W, Zeng F, Wu Z, Jin Z, Li W, Zhu M, Wang Q, Tong Y, Chen L, Bai Q (2021) Isolation and genomic analysis of temperate phage 5W targeting multidrug-resistant Acinetobacter baumannii. Arch Microbiol 204:58CrossRefPubMed
6.
7.
go back to reference Gill JJ, Hyman P (2010) Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol 11:2–14CrossRefPubMed Gill JJ, Hyman P (2010) Phage choice, isolation, and preparation for phage therapy. Curr Pharm Biotechnol 11:2–14CrossRefPubMed
8.
go back to reference Zeng H, Li C, Luo D, Zhang J, Ding Y, Chen M, Yang X, Lei T, Wu S, Ye Q, Pang R, Gu Q, Wu Q (2021) Novel phage vB_CtuP_B1 for controlling Cronobacter malonaticus and Cronobacter turicensis in ready-to-eat lettuce and powered infant formula. Food research international (Ottawa, Ont) 143:110255 Zeng H, Li C, Luo D, Zhang J, Ding Y, Chen M, Yang X, Lei T, Wu S, Ye Q, Pang R, Gu Q, Wu Q (2021) Novel phage vB_CtuP_B1 for controlling Cronobacter malonaticus and Cronobacter turicensis in ready-to-eat lettuce and powered infant formula. Food research international (Ottawa, Ont) 143:110255
9.
go back to reference Pehde BM, Niewohner D, Keomanivong FE, Carruthers MD (2021) Genome Sequence and Characterization of Acinetobacter Phage DMU1. PHAGE (New Rochelle, NY) 2:50–56 Pehde BM, Niewohner D, Keomanivong FE, Carruthers MD (2021) Genome Sequence and Characterization of Acinetobacter Phage DMU1. PHAGE (New Rochelle, NY) 2:50–56
10.
go back to reference Duan S, Dong Y, Xu Y, Yin J, Geng L, Xiu Z (2022) One-step salting-out extraction of bacteriophage from its infection broth of Acinetobacter baumannii. J Chromatogr A 1679:463407CrossRefPubMed Duan S, Dong Y, Xu Y, Yin J, Geng L, Xiu Z (2022) One-step salting-out extraction of bacteriophage from its infection broth of Acinetobacter baumannii. J Chromatogr A 1679:463407CrossRefPubMed
11.
go back to reference Kropinski AM (2018) Practical Advice on the One-Step Growth Curve. Methods in molecular biology. (Clifton NJ) 1681:41–47 Kropinski AM (2018) Practical Advice on the One-Step Growth Curve. Methods in molecular biology. (Clifton NJ) 1681:41–47
12.
go back to reference Jończyk-Matysiak E, Łodej N, Kula D, Owczarek B, Orwat F, Międzybrodzki R, Neuberg J, Bagińska N, Weber-Dąbrowska B, Górski A (2019) Factors determining phage stability/activity: challenges in practical phage application. Expert Rev anti-infective therapy 17:583–606CrossRefPubMed Jończyk-Matysiak E, Łodej N, Kula D, Owczarek B, Orwat F, Międzybrodzki R, Neuberg J, Bagińska N, Weber-Dąbrowska B, Górski A (2019) Factors determining phage stability/activity: challenges in practical phage application. Expert Rev anti-infective therapy 17:583–606CrossRefPubMed
13.
go back to reference Soleimani-Delfan A, Bouzari M, Wang R (2021) A rapid competitive method for bacteriophage genomic DNA extraction. J Virol Methods 293:114148CrossRefPubMed Soleimani-Delfan A, Bouzari M, Wang R (2021) A rapid competitive method for bacteriophage genomic DNA extraction. J Virol Methods 293:114148CrossRefPubMed
14.
go back to reference Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA (2012) SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput biology: J Comput Mol cell biology 19:455–477MathSciNetCrossRef Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA (2012) SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput biology: J Comput Mol cell biology 19:455–477MathSciNetCrossRef
15.
go back to reference Bouras G, Nepal R, Houtak G, Psaltis AJ, Wormald PJ, Vreugde S (2023) Pharokka: a fast scalable bacteriophage annotation tool. Bioinf (Oxford England) 39(1):btac776 Bouras G, Nepal R, Houtak G, Psaltis AJ, Wormald PJ, Vreugde S (2023) Pharokka: a fast scalable bacteriophage annotation tool. Bioinf (Oxford England) 39(1):btac776
16.
go back to reference Jiang JZ, Yuan WG, Shang J, Shi YH, Yang LL, Liu M, Zhu P, Jin T, Sun Y, Yuan LH (2023) Virus classification for viral genomic fragments using PhaGCN2. Brief Bioinform 24(1):bbac505CrossRefPubMed Jiang JZ, Yuan WG, Shang J, Shi YH, Yang LL, Liu M, Zhu P, Jin T, Sun Y, Yuan LH (2023) Virus classification for viral genomic fragments using PhaGCN2. Brief Bioinform 24(1):bbac505CrossRefPubMed
17.
go back to reference Moraru C, Varsani A, Kropinski AM (2020) VIRIDIC-A Novel Tool to Calculate the Intergenomic Similarities of Prokaryote-Infecting Viruses. Viruses 12(11):1268CrossRefPubMedPubMedCentral Moraru C, Varsani A, Kropinski AM (2020) VIRIDIC-A Novel Tool to Calculate the Intergenomic Similarities of Prokaryote-Infecting Viruses. Viruses 12(11):1268CrossRefPubMedPubMedCentral
18.
go back to reference Price MN, Dehal PS, Arkin AP (2009) FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol 26:1641–1650CrossRefPubMedPubMedCentral Price MN, Dehal PS, Arkin AP (2009) FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol Biol Evol 26:1641–1650CrossRefPubMedPubMedCentral
19.
go back to reference Sullivan MJ, Petty NK, Beatson SA (2011) Easyfig: a genome comparison visualizer. Bioinf (Oxford England) 27:1009–1010 Sullivan MJ, Petty NK, Beatson SA (2011) Easyfig: a genome comparison visualizer. Bioinf (Oxford England) 27:1009–1010
20.
go back to reference Sisakhtpour B, Mirzaei A, Karbasizadeh V, Hosseini N, Shabani M, Moghim S (2022) The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage. Ann Clin Microbiol Antimicrob 21:1CrossRefPubMedPubMedCentral Sisakhtpour B, Mirzaei A, Karbasizadeh V, Hosseini N, Shabani M, Moghim S (2022) The characteristic and potential therapeutic effect of isolated multidrug-resistant Acinetobacter baumannii lytic phage. Ann Clin Microbiol Antimicrob 21:1CrossRefPubMedPubMedCentral
21.
go back to reference Zhu Y, Han K, Chen L, Luo S, Fan H, Tong Y (2022) Biological characterization and genomic analysis of Acinetobacter baumannii phage BUCT628. Arch Virol 167:1471–1474CrossRefPubMed Zhu Y, Han K, Chen L, Luo S, Fan H, Tong Y (2022) Biological characterization and genomic analysis of Acinetobacter baumannii phage BUCT628. Arch Virol 167:1471–1474CrossRefPubMed
22.
go back to reference Zhang L, Wang X, Hua X, Yu Y, Leptihn S, Loh B (2022) Therapeutic evaluation of the Acinetobacter baumannii phage Phab24 for clinical use. Virus Res 320:198889CrossRefPubMed Zhang L, Wang X, Hua X, Yu Y, Leptihn S, Loh B (2022) Therapeutic evaluation of the Acinetobacter baumannii phage Phab24 for clinical use. Virus Res 320:198889CrossRefPubMed
23.
go back to reference Mardiana M, Teh SH, Lin LC, Lin NT (2022) Isolation and Characterization of a Novel Siphoviridae Phage, vB_AbaS_TCUP2199, Infecting Multidrug-Resistant Acinetobacter baumannii. Viruses 14(6):1240CrossRefPubMedPubMedCentral Mardiana M, Teh SH, Lin LC, Lin NT (2022) Isolation and Characterization of a Novel Siphoviridae Phage, vB_AbaS_TCUP2199, Infecting Multidrug-Resistant Acinetobacter baumannii. Viruses 14(6):1240CrossRefPubMedPubMedCentral
24.
go back to reference Ma G, Gao X, Jiang C, Xing S, Wei C, Huang P, Lin J (2019) pH-Responsive Nanoprobe for In Vivo Photoacoustic Imaging of Gastric Acid. Anal Chem 91:13570–13575CrossRefPubMed Ma G, Gao X, Jiang C, Xing S, Wei C, Huang P, Lin J (2019) pH-Responsive Nanoprobe for In Vivo Photoacoustic Imaging of Gastric Acid. Anal Chem 91:13570–13575CrossRefPubMed
26.
go back to reference Lai MJ, Soo PC, Lin NT, Hu A, Chen YJ, Chen LK, Chang KC (2013) Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978. Int J Antimicrob Agents 42:141–148CrossRefPubMed Lai MJ, Soo PC, Lin NT, Hu A, Chen YJ, Chen LK, Chang KC (2013) Identification and characterisation of the putative phage-related endolysins through full genome sequence analysis in Acinetobacter baumannii ATCC 17978. Int J Antimicrob Agents 42:141–148CrossRefPubMed
Metadata
Title
Isolation and genome-wide analysis of the novel Acinetobacter baumannii bacteriophage vB_AbaM_AB3P2
Authors
Yujing Tan
Jianhui Su
Dandan Luo
Bingshao Liang
Shenshen Liu
Haiyan Zeng
Publication date
01-03-2024
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 3/2024
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-024-05986-9

Other articles of this Issue 3/2024

Archives of Virology 3/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.